News | June 06, 2023
Unimed to expand operations into Singapore with Marine Pharma merger
Establishes distribution center in top hub for international shipping
Establishes distribution center in top hub for international shipping
Projected ~US$100 million cash balance of combined company expected to fund operations through mid-2025 and to clinical data over the next 12 to 24 months
To create leading company developing medicines targeting metalloenzymes
The two startups will utilise the capital for business growth including strategic expansion, product development, R&D and technology investments
Combined platform with 55+ centres aims to expand integrated maternity, fertility, neonatal and paediatric care across India
Combined company targets Rs. 2,500–3,000 crore revenue by 2030; new sterile and OSD plants to begin operations by August 2026
The CDMO segment saw a 22% decline in Q4 due to a strong base in the prior year
The acquisition positions Roche more aggressively in digital pathology and precision diagnostics capabilities
The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint
At the center of the deal is TERN-701, a drug recently granted Breakthrough Therapy Designation by the U.S. Food and Drug Administration for adults with Philadelphia chromosome-positive chronic myeloid leukemia
Subscribe To Our Newsletter & Stay Updated
